[Industry Voice #28] Craig Lipset on FDA’s Quotes | Big Pharma Standpoint | DCTs скачать в хорошем качестве

[Industry Voice #28] Craig Lipset on FDA’s Quotes | Big Pharma Standpoint | DCTs

Decentralized trials have become a prominent trend in the sphere of clinical research. Recent advancements in #AI and overall #Digitalization have further accelerated the process of decentralization. Join us for an insightful interview with Craig Lipset, a leading figure in digital R&D innovations in the life science industry, CEO & Founder of Clinical Innovation Partners. Explore the current state of decentralized trials, the role of AI and wearables, overcoming barriers to universal adoption, FDA's perspective, patient enrollment and many other related topics in our new #IndustryVoice video podcast episode. 0:00 Introduction 1:21 The status of decentralized clinical trials 4:05 AI in fostering decentralization 7:09 Universal shift to innovative solutions 11:59 FDA’s approach to decentralized studies 15:19 Tipps for patients’ engagement in DCT 18:16 Enrollment via social media channels 20:08 Telemedicine in DCT 23:55 Future of the industry Enjoy and subscribe to our YouTube channel to be the first to know about new content on clinical research. Webpage: https://oct-clinicaltrials.com/. Experience: https://oct-clinicaltrials.com/oct-ex.... Blog, articles, case studies: https://oct-clinicaltrials.com/resources. LinkedIn:   / oct-clinical-trials-in-central-and-eastern...   ✉Reach out to become the next speaker: [email protected] ✉Submit an RFP for clinical services: [email protected] #cro #octclinical #decentralizedclinicaltrials #decentralization #aiclinicaltrials #craiglipset #fda